ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells
Junichi Yamamoto, Tetsufumi Suwa, Yuki Murase, Shumpei Tateno, Hirotaka Mizutome, Tomoko Asatsuma‐Okumura, Nobuyuki Shimizu, Tsutomu Kishi, Shuji Momose, Masahiro Kizaki, Takumi Ito, Yuki Yamaguchi, Hiroshi Handa
Topics & Concepts
PomalidomideLenalidomideMultiple myelomaThalidomideCancer researchMinimal residual diseaseOncologyBiologyMedicineImmunologyLeukemiaProtein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsChromatin Remodeling and Cancer